Osmotic nephrosis due to high-dose immunoglobulin therapy containing sucrose (but not with glycine) in a patient with immunoglobulin A nephritis
- 30 September 1996
- journal article
- case report
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 28 (3) , 451-453
- https://doi.org/10.1016/s0272-6386(96)90505-3
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Acute renal failure associated with immunoglobulin therapyAmerican Journal of Kidney Diseases, 1995
- Strychnine and Glycine Protect Renal Proximal Tubules from Various Nephrotoxicants and Act in the Late Phase of Necrotic Cell InjuryToxicology and Applied Pharmacology, 1994
- Renal Toxicity of Intravenous ImmunoglobulinVox Sanguinis, 1993
- Intravenös verabreichte Immunglobuline beim systemischen Lupus erythematodes: Literaturübersicht und erste klinische ErfahrungenTransfusion Medicine and Hemotherapy, 1993
- Effect of high-dose intravenous immunoglobulin therapy on blood rheologyThe Lancet, 1992
- The cell biology of ischemic renal injuryKidney International, 1991
- Mannitol-Induced Acute Renal FailureMedicine, 1990
- Intravenous γ-globulin therapy in systemic lupus erythematosus and immune complex diseaseClinical Immunology and Immunopathology, 1989
- Nephrotoxicity of contrast mediaKidney International, 1989
- Renal failure associated with low-molecular-weight dextran infusion.BMJ, 1966